Proton therapy and concurrent chemotherapy may reduce bone marrow toxicity
Friday, November 14, 2008 - 13:35
in Health & Medicine
Patients treated for locally advanced non-small cell lung cancer who receive chemotherapy and proton beam therapy have fewer instances of bone marrow toxicity than patients who receive the standard treatment of intensity-modulated radiation (IMRT) and concurrent chemotherapy, according to researchers from The University of Texas M. D. Anderson Cancer Centre...